DOMINION LIFE SCIENCES CORPORATION INTRODUCES RAPISCAN ORAL FLUID DIAGNOSTIC SYSTEM to U.S.
North Kingstown, RI (PRWEB) September 25, 2003
Dominion Life Sciences Corporation, a complete diagnostics services corporation, announces partnership with Cozart Bioscience Ltd., a UK-based medical diagnostics company, to become the EXCLUSIVE U.S. Distributor of Cozart RapiScan, the world’s first integrated on-site oral fluid (saliva) based drugs of abuse diagnostic system.
Â?When you think of new, when you think of innovative, you should be thinking DominionÂ? said Dr. Frank Fornari, Dominion CEO. Â?RapiScan has a wide range of applicability and includes a new, accurate ease of testing (simultaneous results within minutes) for law enforcement, work place, government, medical emergencies, wellness/health screening and more.Â?
The hand held, FDA approved RapiScan detects a broad drugs of abuse menu, including amphetamine, benzodiazepines, cannabinoids, cocaine, opiates, methadone, methamphetamine, phencyclidine, and buprenorphine. Several new panels are currently in development.
RapiScan benefits include:
Cost Effective
Ease of Collection
Lab Quality Accuracy
Multiple Results within Minutes
Sample Adulteration Eliminated
Completely Portable
Dominion Life Sciences Corporation, dedicated to providing diagnostic services that improve the quality of life, is proud to be the EXCLUSIVE U.S. Distributor of Cozart RapiScan.
###
For more information, please contact:
Dominion Life Sciences Corporation
Toll Free: 877.734.9600
National Sales
Jim Longfield
Cell: 303.883.2002
###